Diabetes Research and Clinical Practice
Volume 88, Issue 3 , Pages e24-e27 , June 2010

Prevalence and risk factors for albuminuria among type 2 diabetes mellitus patients: A Middle-East perspective

  • P. Prashanth

      Affiliations

    • Department of Medicine, Royal Hospital, Muscat, Oman
    • Corresponding Author InformationCorresponding author at: Department of Medicine, Royal Hospital, PB 1331, Seeb, Muscat 111, Oman. Tel.: +968 92603746; fax: +968 24599841.
    • ,
  • K.J. Sulaiman

      Affiliations

    • Department of Medicine, Royal Hospital, Muscat, Oman
    • ,
  • G. Kadaha

      Affiliations

    • Department of Medical Affairs, Sanofi-Aventis Gulf Countries, Dubai Health Care City, Dubai, United Arab Emirates
    • ,
  • N. Bazarjani

      Affiliations

    • Department of Medical Affairs, Sanofi-Aventis Gulf Countries, Dubai Health Care City, Dubai, United Arab Emirates
    • ,
  • S. Bakir

      Affiliations

    • Department of Medical Affairs, Sanofi-Aventis Gulf Countries, Dubai Health Care City, Dubai, United Arab Emirates
    • ,
  • K. El Jabri

      Affiliations

    • Department of Medical Affairs, Sanofi-Aventis Gulf Countries, Dubai Health Care City, Dubai, United Arab Emirates
    • ,
  • F. Al Sabr

      Affiliations

    • Department of Medical Affairs, Sanofi-Aventis Gulf Countries, Dubai Health Care City, Dubai, United Arab Emirates
    • ,
  • H. Mahmoud

      Affiliations

    • Department of Medical Affairs, Sanofi-Aventis Gulf Countries, Dubai Health Care City, Dubai, United Arab Emirates
    • ,
  • for the DEMAND Gulf Study Investigators

Received 12 August 2009 ,Revised 6 September 2009 ,Accepted 2 February 2010.

References 

  1. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286:421–426
  2. Diabetes Atlas, third edition ©International Diabetes Federation. http://www.eatlas.idf.org/media/, 2006 (accessed 24.10.08).
  3. Parving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG. DEMAND investigators: prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int. 2006;69:2057–2063
  4. Pan CY, Ho LT, Soegondo S, Prodjosudjadi W, Suwanwalaikorn S, Lim SC, et al. DEMAND study investigators: prevalence of albuminuria and cardiovascular risk profile in a referred cohort of patients with type 2 diabetes: an Asian perspective. Diabetes Technol. Ther. 2008;10:397–403
  5. Rossi MCE, Nicolucci A, Pellegrini F, Comaschi M, Ceriello A, Cucinotta D, et al. Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND study. Nephrol. Dial. Transplant. 2007;0:1–7
  6. Al-Futaisi A, Al-Zakwani I, Almahrezi A, Al-Hajri R, Al-Hashmi L, Al-Muniri A, et al. Prevalence and predictors of microalbuminuria in patients with type 2 diabetes mellitus: a cross-sectional observational study in Oman. Diabetes Res. Clin. Pract. 2006;72:212–215
  7. Glans F, Elgzyri T, Shaat N, Lindholm E, Apelqvist J, Groop L. Immigrants from the Middle-East have a different form of Type 2 diabetes compared with Swedish patients. Diabet. Med. 2008;25:303–307
  8. Alberti KG, Zimmet PZ. Definition diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus, provisional report of a WHO Consultation. Diabet. Med. 1998;15:539–553
  9. Heerspink HL, Brantsma AH, Zeeuw D, Bakker SL, Jong PE, Gansevoort RT. Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality: for the PREVEND Study Group. Am. J. Epidemiol. 2008;168:897–905
  10. Beamer NB, Coull BM, Clark WM, Wynn M. Microalbuminuria in ischemic stroke. Arch. Neurol. 1999;56:699–702
  11. Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE, et al. Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE study. Diabetes Care. 2006;29:595–600

PII: S0168-8227(10)00065-3

doi: 10.1016/j.diabres.2010.02.004

Diabetes Research and Clinical Practice
Volume 88, Issue 3 , Pages e24-e27 , June 2010

Article Tools